ABSTRACT
Background Pericardiectomy is definitive treatment for constrictive pericarditis. However, extent of resection (radical versus partial) and use of cardiopulmonary bypass (CPB) are debated.
Objectives To determine the association of extent of pericardial resection and use of CPB with outcomes.
Methods From January 2000 to January 2022, 565 patients with constrictive pericarditis underwent radical (n=445, 314 [71%] on CPB) or partial (n=120, 67 [56%] on CPB) pericardiectomy at Cleveland Clinic. Outcomes stratified by extent of pericardial resection and use of CPB were compared after propensity-score matching.
Results Both radical pericardiectomy and CPB use (67% [381/565]) increased over time. Among 88 propensity-matched pairs (73% of possible matches), immediate postoperative cardiac index increased (P<0.001) in both groups by a median of 1.0 L•min-1•m-2. There were no significant differences between radical versus partial resection groups in occurrence of reoperation for bleeding (2.3%, [2/88] vs. 0, P=.50). Median postoperative hospital length of stay was 10 versus 8.5 days (P=.02). Operative mortality was 9.1% (8/88) versus 6.8% (6/88) (P=.58). 10-year survival was 54% versus 41%, with a higher propensity-adjusted hazard ratio after partial resection (1.9, 95% CI 1.2-3.1).
Conclusions When surgical intervention is deemed necessary, radical — rather than partial — resection for constrictive pericarditis can be performed with low surgical mortality and morbidity. Radical pericardiectomy can be accomplished on CPB and results in better long-term survival.
CLINICAL PERSPECTIVES
Patients with constrictive pericarditis require a multidisciplinary approach involving primarily a cardiologist and cardiac surgeon, and other disciplines like gastroenterology since liver cirrhosis from increased central venous pressure and congestion is common, or immunology for evaluation of possible autoimmune etiology.
Communication is critical in managing patient expectations after pericardiectomy, especially linking etiology to short- and long-term outcomes in this complex patient population.
Radical pericardiectomy should be the gold standard for treating patients with constrictive pericarditis.
Routine use of cardiopulmonary bypass is safe and enables the radical pericardiectomy surgery and should be recommended in the guidelines.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported in part by the Drs. Sidney and Becca Fleischer Heart and Vascular Education Chair (EHB).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Clinical data were extracted prospectively for quality assurance. Cleveland Clinic's Institutional Review Board approved use of these data for research, with patient consent waived (IRB #5001; approved 2/26/2021).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵1 Co-directors, The Center for Diagnosis and Treatment of Pericardial Diseases, Miller Family Heart, Vascular & Thoracic Institute, Cleveland Clinic
Data Availability
Clinical data were extracted prospectively for quality assurance. Cleveland Clinic's Institutional Review Board approved use of these data for research, with patient consent waived (IRB #5001; approved 2/26/2021). Data can be provided for quality assurance and review with appropriate protocol, processes and mutual agreement.
ABBREVIATIONS
- COPD
- chronic obstructive pulmonary disease
- CPB
- cardiopulmonary bypass
- ECMO
- extracorporeal membrane oxygenation
- IABP
- intra-aortic balloon pump
- IVC
- inferior vena cava
- LVAD
- left ventricular assist device
- SVC
- superior vena cava
